South African Government to Appeal Court Ruling Forcing It to Provide Key AIDS Drug

Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

South African Government to Appeal Court Ruling Forcing It to Provide Key AIDS Drug

Associated Press (12.19.01) - Wednesday, December 19, 2001
Mike Cohen

The South African government said Wednesday it would appeal a court ruling compelling it to provide a key AIDS drug to HIV- positive pregnant women that would lower chances of passing the virus on to their children. "We have instructed our legal counsel to appeal the judgment to the Constitutional Court as soon as practicable," Health Minister Manto Tshabalala-Msimang said in a statement. The Pretoria High Court ruled Friday that the government has to make nevirapine available countrywide. Studies show nevirapine can reduce the transmission of HIV from mother-to-child during labor by up to 50 percent. They also ordered the government to institute a comprehensive nationwide program to reduce mother-to-child transmission of HIV and gave the government until March to report on how the program - which is to include counseling, HIV testing and the distribution of baby formula - was being implemented.

"Having examined the reasoning of the judgment and the orders made, we came to the conclusion that this judgment could have far-reaching implications in defining our constitutional democracy and in shaping the state's responsibility for the delivery of social services," said Tshabalala-Msimang.

Tshabalala-Msimang said the appeal was not an attempt by the government to obstruct the development of a program to prevent mother-to-child transmission of HIV. "Rather it is aimed at clarifying a constitutional and jurisdictional matter which, if left vague, could throw executive policy making into disarray and create confusion about the principle of the separation of powers, which is a cornerstone of our democracy," she said.

The government's decision to challenge the High Court ruling was regrettable, said Nathan Geffen, a spokesperson for the Treatment Action Campaign, which lodged the lawsuit. "We are concerned that this delay will result in further unnecessary HIV infections and loss of life," he said.
011219
AD012198

Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.